Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Early Medical Affairs Collaboration Secures Promotional Content Integrity

Early collaboration between brand and medical teams can prevent costly delays and improve promotional content credibility. In this discussion, key strategies are shared to enhance collaboration including early involvement, clear communication, and effective claims management. These tactics are crucial in maintaining scientific rigor and compliance throughout the content development process.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Vodori on MarketScale.

By Annalise Ludtke · Grace MacalinoPromotional Content DevelopmentPromotional Content ReviewPromotional Material Review Process
Share
Early Medical Affairs Collaboration Secures Promotional Content Integrity

Key takeaways

01

Early involvement of medical affairs is crucial to ensuring compliance and scientific integrity.

02

Clear communication between teams helps align goals and manages expectations.

03

Developing a claims matrix early can streamline the content review process.

Strong alignment between brand and medical affairs teams is essential in today’s evolving promotional content landscape. Ensuring seamless collaboration can enhance content quality and efficiency. Effective collaboration between these teams can significantly streamline processes and improve the quality of promotional materials​

Effective collaboration between these teams can significantly streamline processes and improve the quality of promotional materials.

What are the key strategies to foster better collaboration between brand and medical affairs teams in 2024?

On this episode of Amend & Progress by Vodori, host Annalise Ludtke discusses with Grace Macalino, a scientific strategy and medical affairs consultant, the nuances of improving the relationship between brand and medical affairs teams. This discussion covers best practices for collaboration, challenges faced during promotional content review, and strategies to ensure rigorous and compliant content creation.

Main Points of Conversation:

  • Early Involvement: Bringing medical affairs into the content development process early can prevent many issues down the line, ensuring that scientific rigor and compliance are maintained from the start.
  • Clear Communication: Establishing open lines of communication and mutual understanding between the teams can help manage expectations and align goals effectively.
  • Claims Management: Developing a comprehensive claims matrix early in the campaign planning process can streamline promotional content review and reduce unnecessary revisions.

Grace Macalino is a seasoned consultant in scientific strategy and medical affairs. With a background in epidemiology, she has dedicated her career to bridging the gap between scientific research and commercial strategy. Grace has worked with numerous pharmaceutical companies to enhance their medical affairs strategies and improve collaboration with brand teams.

Vodori

Part of this channel

Vodori

Faster market access through compliant life science content review.

Visit the channel

About the author

AL
Annalise Ludtke

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

GM
Grace Macalino

Scientific Strategy and Medical Affairs Consultant

Grace Macalino is a seasoned consultant in scientific strategy and medical affairs. With a background in epidemiology, she has dedicated her career to bridging the gap between scientific research and commercial strategy. Grace has worked with numerous pharmaceutical companies to enhance their medical affairs strategies and improve collaboration with brand teams.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512